期刊文献+

淋球菌对氟喹诺酮类药物敏感性及其耐药机制的研究(英文) 被引量:1

Study on fluoroquinolone susceptibility and resistance mechanism in clinical isolates of Neisseria gonorrhoeae
下载PDF
导出
摘要 目的了解长沙地区淋球菌流行株对氟喹诺酮类药物的耐药现状,探讨淋球菌对氟喹诺酮类药物耐药的分子机制。方法纸片扩散法检测126株淋球菌对4种氟喹诺酮类药物的敏感性。E-test法定量检测其中63株淋球菌环丙沙星的最小抑菌浓度(MIC)。对淋球菌喹诺酮类药物作用靶位编码基因gyrA和parC的喹诺酮耐药决定区(QRDR)进行PCR扩增和直接测序分析。结果淋球菌对氧氟沙星、氟罗沙星、洛美沙星、依诺沙星耐药率分别为70.6%、81.7%、72.2%和82.5%。环丙沙星MIC为0.004~12.0μg/mL,耐药率65.1%。对环丙沙星敏感的菌株gyrA和parC基因均未发生突变,而中介或耐药菌株均出现gyrA突变或同时伴有parC突变,且所有parC突变均发生在gyrA突变基础上。突变位点包括gyrA上Ser91→Tyr,Ser91→Phe,Asp95→Gly,Asp95→Ala,Asp95→Asn以及parC上Gly85→Cys、Asp86→Asn、Ser87→Arg、Ser87→Ile、Ser87→Asn、Ser88→Pro、Glu91→Lys、Glu91→Gly。其中以gyrASer91→Phe频率最高。结论长沙地区淋球菌流行株对氟喹诺酮类药物耐药已十分严重。淋球菌对氟喹诺酮类药物耐药与gyrA和parC基因突变密切相关;GyrASer91→Phe是形成该耐药性的关键突变。多位点突变具有协同作用,可使耐药性进一步增强。 [Objeetive] To evaluate the situation of Fluroquinolone resistance in Neisseria Gonorrhoeae in Changsha, P.R.China and to investigate the molecular mechanisms of Fluoroquinolone resistance in clinical isolates of Neisseria Gonorrhoeae. [Methods] The susceptibilities of 126 clinical isolates of N.gonorrhoeae to 4 Fluorcquinolones were tested by disc diffusion method. The minimum inhibitory concentration (MIC) of Ciprofloxacin was determined by E-test method in 63 strains. The fragments including quinolone resistance-determining region (QR- DR) were amplified by PCR in gyrA and parC genes, and their relative fragments were directly sequenced. [Resuits] The percentages of resistance to Ofloxacin, Fleroxacin, Lomefloxacin, and Enoxacin were 70.6%, 81.7%, 72.2% and 82.5% respectively. Range of ciprofloxacin MIC was 0.004-12.0 μg/mL in 63 strains. Percentage of resistance was 65.1%. Ciprofloxacin-susceptible strains contained no mutation in gyrA and parC genes,while intermediate or resistant strains contained mutations in gyrA gene, and some contained mutations in parC gene simultaneously. All parC gene mutations were found on the basis of mutations in gyrA gene. These amino substitutions included Sergl→Tyr, Ser91→Phe, Asp95→Gly, Asp95→Ala, Asp95→Asn in GyrA and Gly85→Cys, Asp86→Asn, Ser87→Arg, Ser87→Ile, Ser87→Asn, Ser88→Pro, Glu91→Lys, Glu91→Gly in ParC. Of all the mutations in gyrA gene,the percentage of substitution of Ser91→Phe was the highest. [Conclusions] Fluoroquinolone resistanee in N. gonorrhoeae in Changsha, P.R.China is very severe at present. Fluoroquinolone resistance in N.gonorrhoeae has close relationship with mutations in gyrA and parC genes. Substitution of Ser91→Phe in gyrA gene is the pivotal mutation resulting in fluoroquinolone resistance in N.gonorrhoeae. The eooperation of multi-point mutations makes the resistance stronger.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第10期1447-1452,共6页 China Journal of Modern Medicine
基金 Supported by a foundation from science and technology department of Hunan province(NO:03JZY3031) health department of Hunan province(NO:B2003-041)
关键词 奈瑟氏球菌 淋病 氟喹诺酮 药物敏感性 GYRA基因 PARC基因 点突变 Neisseria Gonorrhoeae fluorocluinolone antimicrobial susceptibility gyrA gene parC gene point mutation
  • 相关文献

参考文献2

二级参考文献14

  • 1郑专杰,王睿.嗜麦芽窄食单胞菌的耐药机制[J].国外医学(呼吸系统分册),2005,25(1):34-37. 被引量:29
  • 2WINCENT JL,BIHARI DJ,SUTER PM,et al.The prevalenceof nosocomial infection in intensive care units in Europe[J].JAMA,1995,274(8):639.
  • 3WEBER DJ,RAASCH R,RUTALA WA.Nosocomial infections inthe ICU[J].Chest,1999,15(3):34s-40s.
  • 4FRIDKIN SK,HAGEMAN J,MCDOUGAL L K,et al.Epidemiological and microbiological characterization of infections eausedby Staphylococcus aureus with reduced susceptibility to vancomycin[J].United States,1997-2001.Clin Infect Dis,2003,36(4):429-439.
  • 5PALLERONI NJ,BRADBURY JF.Stenotrophomonas,a new bacterial genus for xanthomonas maltophilia (Hugh 1989) Swings et al.1983[J].Int J Syst Bacteriol,1993,43:606-609.
  • 6FUJITA J,YAMADORI I,XU G,et al.Clinical feature of Stenotrophomonas maltophilia pneumonia in immunocompromised patients[J].Respir Med,1996,90:35-38.
  • 7DUFRESNE J,VEZINA G,LEVESQUE RC.Coloning and expression of the imipenem-by draysing B-Lactamase operonfro pseudomonas maltophilia in Escherichia Coil[J].Antimicrob Agents Chemoother,1988,32:819-826.
  • 8BARTLETT J G.Pocket Book of Infectious disease therapy[M].Philadelphia:Lippincott Willams and Wilkins,2002:19.
  • 9徐英春,陈民钧,周贵民,张秀珍,王清涛,许淑珍.396株嗜麦芽窄食单胞菌的耐药特征研究[J].中华微生物学和免疫学杂志,1999,19(3):184-187. 被引量:49
  • 10杨立军,林桂秋,王素兰,李春英.嗜麦芽窄食单胞菌临床感染诱因及耐药分析[J].中华医院感染学杂志,1999,9(3):140-142. 被引量:68

共引文献13

同被引文献22

  • 1陈宏翔,涂亚庭,林能兴,黄长征,张丽霞.淋球菌多重耐药性与mtrR基因点突变的关系[J].华中科技大学学报(医学版),2005,34(5):616-618. 被引量:8
  • 2向丽,张育华,王光西.淋球菌耐药基因的研究进展[J].寄生虫病与感染性疾病,2006,4(2):87-89. 被引量:2
  • 3谢国艳,应春妹,周建华.耐氟喹诺酮淋病奈瑟菌基因突变研究[J].诊断学理论与实践,2006,5(3):243-246. 被引量:2
  • 4蒋法兴,其木格,王千秋.染色体介导淋球菌耐药机制的进展[J].国际皮肤性病学杂志,2006,32(5):327-329. 被引量:4
  • 5张铁军,周晓明,张涛,姜庆五.淋球菌分离株耐药质粒谱型研究[J].中国皮肤性病学杂志,2007,21(3):144-146. 被引量:8
  • 6Ray K, Bala M, Kumari S, et al. Antimicrobial resistance of neisse- ria gonorrhoeae in selected world health organization southeast asia region countries : an overview [ J ]. Sex Transm Dis, 2005,32 ( 3 ) : 178-184.
  • 7Powell A J, Tomberg J, Deacon AM, et al. Crystal structures of peni- cillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance [ J ]. J Biol Chem, 2009,284 (2) :1202-1212.
  • 8Ropp PA, Hu M, Olesky M,et al. Mutation in ponA, the gene enco- ding penicillin-binding protein 1, and a novel locus, penC, are re- quired for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae [ J ]. Antimicrub Agents Chemother,2002, 46(3) :769-777.
  • 9Tanaka M ,Takahashi K, Saika T, et al. Development of fluoroquin- olone resistance and mutations involving GyrA and ParC proteins a- mong Neisseria gonorrhoreae isolates in Japan [ J ]. J Urol, 1998, 159(6) :2215-2219.
  • 10Rouquette-Loughlin C,Dunham SA, Kuhn M, et al. The NorM ef- flux pump of Neisseria gonorrhieaegnd Neisseria meningitides rec- ognizes antimicrobial cationic compounds [ J ]. J Bacteriol, 2003, 185(23) :1101-1106.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部